Yahoo Finance Results
- Fortune via Yahoo FinanceNov 29 14:42 PM
Bayer AG plans to cut 12,000 jobs and exit its animal health business in an effort to mollify Wall Street, which has punished the company over the tidal wave of lawsuits that came alongside the $63 billion takeover of Monsanto Co.
Pain Management Market Witness a Remarkable Growth at 6.0% CAGR Projected By 2023 | Recent Trends, Demand, Size, Share Analysis by MRFRMarket Watch18 hours ago
Easton Pharmaceuticals Provides Company Update Including Hotel Acquisition in Toronto, BAYER Agreement and Casino Resort in GreeceOmaha World-Herald14 hours ago
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) - 5 Biotech Companies To Keep On Your M&A...Benzinga3 days ago
- Zacks via Yahoo FinanceNov 23 13:58 PM
Both the drugs gained approval for the treatment of acute myeloid leukemia (AML), a rare blood cancer in newly diagnosed patients. The Committee for Medicinal Products for Human Use (CHMP) of ...
Bayer Pharma AG develop, manufacture, and market healthcare products. It provides treatment for cancer such as, colorectal cancer, gastrointestinal stromal tumor, liver cancer, prostate cancer ...
Bayer responded with a white knight bid and in July acquired the majority of shares of Schering for €14.6bn, and in 2007 Bayer took over Schering AG and formed Bayer Schering Pharma. The acquisition of Schering was the largest take-over in Bayer's history,   and as of 2015 was one of the ten biggest pharma mergers of all time.
The U.S. Food and Drug Administration (FDA) inspected your drug manufacturing facility, Bayer Pharma AG at Kaiser-Willhelm-Allee, Building W11, Leverkusen, from January 12–20, 2017.
Bayer Schering Pharma AG manufactures and markets pharmaceuticals. The Company produces x-ray, magnetic resonance imaging, ultrasound, radio pharmaceutical diagnostic equipments, oral ...